Beta blockers have been shown to prolong survival in chronic heart failure. It is currently a matter of debate whether any β blocker is superior to the other in terms of improving symptoms ...

The dose of the first- or second-generation β blocker that the patient is receiving is an important consideration for the switching regimen chosen. The major factors to be kept in mind when ...

Patients with reactive airways disease should, in general, not receive beta-blockers. Because of its relative beta-1 selectivity and titratability, RAPIBLYK TM injection may be titrated to the lowest ...

Beta blockers are go-to meds for many people who've survived a heart attack. However, new Swedish research has found that ...

All patients who have had a heart attack are typically treated using beta blockers. According to a Swedish study conducted earlier this year, this drug is unlikely to be needed for those heart ...

Avoid intra-arterial, periarterial injection. Coronary artery disease ... prostaglandins, beta-blockers. Potent CYP3A4 inhibitors (eg, macrolides, protease inhibitors, reverse transcriptase ...

Research highlights the need to consider mental health impacts when prescribing beta-blockers to MI patients with preserved heart function. Study: Short- and long-term effects of beta-blockers on ...